Method Validation of a Solid Phase Extraction, High Performance Liquid Chromatography and Electrochemical Detection Method for Determination of Azithromycin in Human Plasma

Main Article Content

Sukanya Supattanapong
Julraht Konsil
Bung-orn Sripanidkulchai
Jeffery Roy Johns

Abstract

An effective and sensitive method for the determination of azithromycin in plasma with high performance liquid chromatography (HPLC) and electrochemical detection extracted by solid phase extraction has been developed and validated. Clarithromycin was used as an internal standard. Azithromycin was extracted from 1 ml of plasma by using an Oasis® HLB (Hydrophilic-Lipophilic Balance) solid-phase extraction cartridge. After eluting with 1 ml of methanol, the sample solution was evaporated to dryness, dissolved in 100 μl phosphate buffer-methanol-acetonitrile (60:20:20, v/v/v) and 40 μl injected into the HPLC system. The lower limit of quantitation (LLOQ) was 10 ng/ml without interfering peaks. The calibration curve was linear (r² = 0.9998) over the concentration range from 10 to 400 ng/ml. The accuracy and precision were in acceptable range according to criteria of guideline for Industry: Bioanalytical Method Validation of the US FDA (2001). The mean recoveries at 30, 100 and 200 ng/ml were 85.3±5.5%, 80.1±6.8% and 82.9±2.5%, respectively. Azithromycin was stable in plasma for at least 6 h at room temperature and 6 months stored at -80°C. The post-preparative stability of spiked-samples was stable more than 24 h after preparation. The cartridge can be used two times providing deviation less than 4%. The method can be used for determination of azithromycin in plasma in pharmacokinetic study, bioavailability and bioequivalence.

Downloads

Download data is not yet available.

Article Details

Section
Pharmacy

References

Bahrami G, Mirzae S, Kiani A. 2005. High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies. J Chromatogr B 820: 277-281.

Bahrami G, Mohammadi B. 2006. A new on-line, intube pre-column derivatization technique for high performance liquid chromatographic determination of azithromycin in human swum. J Chromatogr B 830(2); 355-358.

Breitschwerdt EB, Papich MG, Hegarty BC, et al. 1999. Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob Agents Chemother 43(4): 813-821.

Carceles CM, Font A, Espuny A, et al. 2005. Pharmacokinetics of azithromycin after intravenous and intramuscular

administration to goats. J Vet Pharmacol Ther 28(1); 51-55.

Chen BM, Liang YZ, Chen X, et al. 2006. Quantitative determination of azithromycin in human plasma by liquid chromatographymass spectrometry and its application in a bioequivalence study. J Pharm Biomed Anal 42(4);480-487.

Chen L, Qin F, Ma ¥1 et al. Quantitative determination of azithromycin in human plasma by ultra-performance liquid

chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Techno! Biomed Life Sci 2007; 855(2): 255-261. Epub 2007 May 26.

Hardy DJ, Hensey DM, Beyer JM, et al. 1988. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 32(11); 1710-1719.

Hidy BJ, Lewis J, Ke J. Quantitation of Azithromycin in Human Plasma via HPLC with MS/'MS Detection. http://www.aapspharmsci.org/abstracts/AM_2002fAAPS2002-000324.pdf. Accessed June 16, 2008.

Hoepelmana IM, Schneide MME. 1995. Azithromycin: the first of the tissue-selective azalides. Inf J Antimicrob Agents 5: 145-167.

Kees F, Spangler S, Wellenhofer M. 1998. Determination of macrolides in biological matrices by high performance liquid chromatography with electrochemical detection. J Chromatogr A 812; 287-293.

Liu F, Xu Y, Huang J, et al. 2007. Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma. Biomed Chromatogr 21(12); 1272-1278.

Riedel K-D, Wildfeuer A. Laufen H. et al. 1992. Equivalence of a HPLC assay and a bioassay of azithromycin in human serum samples. J Chromatogr 576; 358-362.

U.S. Department of Health and Human Services Food and Drug Administration (US FDA); Guidance for Industry; Bioanalytical Method Validation. 2001. http://www.fda.gov/cder/guidance/4252fnl.pdf. Accessed May 2, 2006.

Xue-Min z, Jie L, Juan G. et al. 2007. Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics. Pharmazie 62(4): 255-257.